How to turn $10,000 into $100,000 with ASX shares

Turning $10,000 into $100,000 might sound ambitious, but it is far from impossible.

If an investor can achieve an average return of around 10% per year, the power of compounding can gradually turn a relatively small starting investment into something much larger.

Of course, returns are never guaranteed and markets can be volatile in the short term. But for investors willing to take a long-term approach, compounding can be a powerful force.

The power of compounding

If an investor started with $10,000 and a balanced ASX share portfolio, and earned a 10% annual return, doing nothing else, the investment would grow significantly over time.

At that rate, it would take just under 25 years for the original $10,000 to grow into roughly $100,000.

That might feel like a long time. But the key point is that the growth accelerates over time as returns begin generating returns of their own. This is the core idea behind compounding.

The good news is that investors don’t have to rely solely on a one-off investment. Regular contributions can dramatically speed up the process.

For example, starting with $10,000 and then adding $500 a month to ASX shares would take just 8.5 years to reach $100,000 with a 10% per annum average return.

How to aim for a 10% return

While no return is guaranteed, many investors aim for long-term returns of around 10% by focusing on high-quality ASX shares that can grow their earnings over time.

The key is not trying to predict short-term market movements. Instead, the focus is on owning companies with strong competitive positions and long runways for expansion.

Many successful ASX growth companies share several common characteristics.

First, they often operate in industries benefiting from structural growth. Technology, healthcare, and digital platforms are good examples where demand continues to expand globally.

Second, the best businesses tend to have scalable business models. Once their platforms or products are built, they can grow revenue much faster than costs, which can drive strong profit growth.

Third, strong competitive advantages are important. Companies with powerful brands, specialised technology, or deep customer relationships are often harder for competitors to disrupt.

This is why long-term investors often look at companies such as Goodman Group (ASX: GMG), Pro Medicus Ltd (ASX: PME), WiseTech Global Ltd (ASX: WTC), and Xero Ltd (ASX: XRO) when searching for businesses with the potential to compound earnings over many years.

Staying invested for the long term

Perhaps the most important factor in turning $10,000 into $100,000 is time.

Even the best companies experience periods where their share prices fall due to market sentiment, interest rate changes, or economic uncertainty. Investors who focus too much on short-term volatility can end up selling great businesses too early.

Instead, the long-term approach is often about staying invested in high-quality companies and allowing their growth to compound over time.

When combined with regular investing and patience, this strategy has the potential to gradually transform a modest starting investment into a much larger portfolio.

The post How to turn $10,000 into $100,000 with ASX shares appeared first on The Motley Fool Australia.

More reading

• 2 ASX growth shares tipped to double in value
• Where to invest $20,000 in ASX shares after the market selloff
• 2 ASX growth stocks to buy now and hold for 10 years
• 5 things to watch on the ASX 200 on Friday
• Goodman, Scentre Group, Stockland: Why are ASX 200 real estate stocks tumbling in 2026?

Motley Fool contributor James Mickleboro has positions in Goodman Group, Pro Medicus, WiseTech Global, and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goodman Group, WiseTech Global, and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended WiseTech Global and Xero. The Motley Fool Australia has recommended Goodman Group and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.